🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
18,54 USD
Máx. histórico
178,74
2142 días
Split 1:6 del 12/07/2012
Caída desde máximo
-89,63%
Rango 52 semanas
14,68 – 24,68
Variación hoy
+1,20%
Cierre anterior
18,32
Rango de hoy
18,29 – 18,81
Volumen hoy
1.397.929
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,44%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 18 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/09/2023 | 120,00 | 120,30 | 110,56 | 114,74 | -4,33% | 8,12% | 1.712.900 |
| 22/09/2023 | 120,00 | 121,82 | 119,65 | 119,93 | +0,32% | 1,81% | 553.400 |
| 21/09/2023 | 117,32 | 119,80 | 117,27 | 119,55 | +1,34% | 2,16% | 838.100 |
| 20/09/2023 | 118,85 | 118,85 | 117,41 | 117,97 | -0,96% | 1,21% | 732.300 |
| 19/09/2023 | 118,66 | 120,11 | 118,10 | 119,11 | +0,90% | 1,69% | 726.700 |
| 18/09/2023 | 117,79 | 118,65 | 116,98 | 118,05 | -0,30% | 1,42% | 722.200 |
| 15/09/2023 | 119,40 | 120,05 | 117,40 | 118,40 | -1,10% | 2,22% | 1.031.400 |
| 14/09/2023 | 119,47 | 120,48 | 119,00 | 119,72 | +0,62% | 1,24% | 629.000 |
| 13/09/2023 | 119,69 | 120,53 | 118,03 | 118,98 | -0,73% | 2,09% | 536.300 |
| 12/09/2023 | 118,03 | 120,79 | 117,88 | 119,85 | +1,22% | 2,47% | 653.300 |
| 11/09/2023 | 120,05 | 120,63 | 118,22 | 118,40 | -1,26% | 2,01% | 801.300 |
| 08/09/2023 | 121,89 | 122,55 | 119,45 | 119,91 | -1,71% | 2,54% | 675.500 |
| 07/09/2023 | 122,62 | 122,87 | 121,65 | 122,00 | -0,70% | 0,99% | 690.200 |
| 06/09/2023 | 120,77 | 123,17 | 120,16 | 122,86 | +1,90% | 2,49% | 1.115.100 |
| 05/09/2023 | 122,04 | 122,55 | 119,36 | 120,57 | -1,58% | 2,61% | 913.600 |
| 01/09/2023 | 121,53 | 123,34 | 121,17 | 122,51 | +1,24% | 1,79% | 596.200 |
| 31/08/2023 | 119,83 | 121,40 | 119,35 | 121,01 | +1,07% | 1,71% | 755.200 |
| 30/08/2023 | 120,11 | 120,74 | 119,15 | 119,73 | -0,24% | 1,32% | 917.800 |
| 29/08/2023 | 118,90 | 121,23 | 118,63 | 120,02 | +1,20% | 2,19% | 609.900 |
| 28/08/2023 | 119,69 | 119,69 | 117,25 | 118,60 | -0,34% | 2,04% | 895.500 |
| 25/08/2023 | 116,66 | 119,75 | 115,62 | 119,00 | +2,59% | 3,54% | 1.289.400 |
| 24/08/2023 | 114,46 | 116,87 | 113,56 | 116,00 | +1,35% | 2,89% | 756.700 |
| 23/08/2023 | 114,50 | 115,52 | 113,45 | 114,46 | +0,68% | 1,81% | 720.900 |
| 22/08/2023 | 113,30 | 114,17 | 112,23 | 113,69 | -0,06% | 1,71% | 431.700 |
| 21/08/2023 | 112,09 | 114,27 | 111,32 | 113,76 | +1,67% | 2,63% | 551.300 |
| 18/08/2023 | 108,80 | 112,13 | 108,01 | 111,89 | +0,87% | 3,79% | 1.219.500 |
| 17/08/2023 | 114,15 | 114,36 | 109,73 | 110,92 | -2,68% | 4,06% | 813.300 |
| 16/08/2023 | 113,00 | 114,91 | 112,78 | 113,97 | -0,10% | 1,88% | 1.216.000 |
| 15/08/2023 | 112,75 | 114,65 | 112,32 | 114,08 | +1,49% | 2,07% | 1.172.700 |
| 14/08/2023 | 108,02 | 112,60 | 107,28 | 112,41 | +4,06% | 4,93% | 1.078.000 |